---
title: "Selected supporting references"
---

<br>

# Our technology

<br>
A subset of references showing elements of our journey in developing and optimising the product and protocols.

<br>

### Overview publication in Drug Discovery World, 26 December 2019
<br>

https://www.ddw-online.com/harnessing-the-modified-proteome-for-increased-diagnostic-power-928-201912/
![](References/ddw.png)

<br><br>

## Technical background
<br>

### [Early predictive AI demonstration](References/ABRF2007_Predictive.pdf)
![](References/Predictive.png)
<br><br>

### [Demonstrating cross lab reproducibility potential](References/SienaPoster_2008.pdf)
![](References/CrossRepo.png)
<br><br>

### [Considerations for powering a clinical proteomics study](References/Jackson et al 2009.pdf)
![](References/Power.png)
<br><br>

### [Introduction to Statistical Process Control](References/SPC in Proteomics Bramwell JProt 2013.pdf)
![](References/SPC1.png)
<br><br>

### [Statistical Process Control for complex samples](References/SPC in Proteomics workflow Bramwell and Jackson JProt 2013.pdf)
![](References/SPC2.png)
<br><br><br><br>


# Disease areas identified as a priority for delivery on the platform
<br><br>

### Health in China

1. [https://www.china-briefing.com/news/china-investment-outlook-telemedicine-digital-healthcare-industry/](https://www.china-briefing.com/news/china-investment-outlook-telemedicine-digital-healthcare-industry/) 
2. Healthy China 2030, see: Xiaodong Tan, Xiangxiang Liu, Haiyan Shao, Healthy China 2030: A Vision for Health Care, Value in Health Regional Issues, Volume 12, 2017, Pages 112-114, [https://doi.org/10.1016/j.vhri.2017.04.001](https://doi.org/10.1016/j.vhri.2017.04.001).
3. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017, Prof Maigeng Zhou, PhD, Haidong Wang, PhD, Xinying Zeng, MS, Peng Yin, PhD, Prof Jun Zhu, MD, Prof Wanqing Chen, PhD et al. [https://doi.org/10.1016/S0140-6736(19)30427-1](https://doi.org/10.1016/S0140-6736(19)30427-1)
4. [World Ageing population 2017, United Nations](https://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2017_Highlights.pdf)
5. [https://knoema.com/atlas/China/Population-aged-65-years-and-above](https://knoema.com/atlas/China/Population-aged-65-years-and-above)
6. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019, The Lancet, GLOBAL HEALTH METRICS| VOLUME 396, ISSUE 10258, P1204-1222, OCTOBER 17, 2020. [https://doi.org/10.1016/S0140-6736(20)30925-9](https://doi.org/10.1016/S0140-6736(20)30925-9)

<br>

### Chronic obstructive pulmonary disease (COPD) {#COPD-link}

1. Chronic obstructive pulmonary disease in China: a nationwide prevalence study, The Lancet Respiratory Medicine, VOLUME 6, ISSUE 6, P421-430, JUNE 01, 2018, [https://doi.org/10.1016/S2213-2600(18)30103-6](https://doi.org/10.1016/S2213-2600(18)30103-6)

<br>

### Alzheimer’s Disease {#AZ-link}

1. 2015 World Alzheimer report. [https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf](https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf)
2. Alzheimer’s Disease International, [https://www.alz.co.uk/research/statistics](https://www.alz.co.uk/research/statistics). 
3. the updated Asia‐Pacific League of Associations for Rheumatology (APLAR) recommendations, updated 2018)

<br>

### Rheumatoid Arthritis {#RA-link}

1. World Health Organisation, Chronic diseases and health promotion - Chronic rheumatic conditions.  [https://www.who.int/chp/topics/rheumatic/en/#:~:text=Rheumatoid%20Arthritis&text=It%20tends%20to%20strike%20during,women%20and%20in%20developed%20countries](https://www.who.int/chp/topics/rheumatic/en/#:~:text=Rheumatoid%20Arthritis&text=It%20tends%20to%20strike%20during,women%20and%20in%20developed%20countries)
2. Ercan, A., Cui, J., Chatterton, D.E.W., Deane, K.D., Hazen, M.M., Brintnell, W., O'Donnell, C.I., Derber, L.A., Weinblatt, M.E., Shadick, N.A., Bell, D.A., Cairns, E., Solomon, D.H., Holers, V.M., Rudd, P.M. and Lee, D.M. (2010), Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis & Rheumatism, 62: 2239-2248. [doi:10.1002/art.27533](https://onlinelibrary.wiley.com/doi/abs/10.1002/art.27533)
3. The top 20 drugs by global sales in 2019, [https://www.fiercepharma.com/special-report/top-20-drugs-by-global-sales-2019](https://www.fiercepharma.com/special-report/top-20-drugs-by-global-sales-2019)


<br><br>

# Additional disease areas identified in the literature


[These papers](AreasLit.html) were selected as demonstrating clinical utility and have analytes suitable for simultaneous measurement by our platform and delivery by the ecosystem.
<br><br>
